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Abstract 
Background: Prior studies examining driving performance have not examined the effects of antiepileptic 
drugs (AED’s) or their dosages in persons with epilepsy. AED’s are the primary form of treatment to 
control seizures, but they are shown to affect cognition, attention, and vision, all which may impair driving. 
The purpose of this study was to describe the characteristics of high and low AED dosages on simulated 
driving performance in persons with seizures. 
Method: Patients (N = 11; mean age 42.1 ± 6.3; 55% female; 100% Caucasian) were recruited from the 
Epilepsy Monitoring Unit and had their driving assessed on a simulator. 
Results: No differences emerged in total or specific types of driving errors between high and low AED 
dosages. However, high AED drug dosage was significantly associated with errors of lane maintenance (r 
= .67, p < .05) and gap acceptance (r = .66, p < .05). The findings suggest that higher AED dosages may 
adversely affect driving performance, irrespective of having a diagnosis of epilepsy, conversion disorder, 
or other medical conditions. 
Conclusion: Future studies with larger samples are required to examine whether AED dosage or seizure 
focus alone can impair driving performance in persons with and without seizures. 
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 When occupational therapists are 
determining an individual’s fitness to drive, they do 
so primarily by conducting comprehensive driving 
evaluations, which typically consist of off- and on-
road assessments.  In many cases, drivers whose 
fitness to drive has been questioned are referred by 
physicians or are flagged by the regulatory licensing 
board.  However, with some medical conditions, 
such as epilepsy, there is a paucity of literature 
concerning how the symptoms or side effects of 
antiepileptic drugs can impair driving performance.  
Current guidelines do not provide strong directions 
for occupational therapists, who, ultimately, are 
responsible for determining how the symptoms and 
medications related to epilepsy can impact an 
individual’s driving ability (National Institute of 
Neurological Disorders and Stroke, n.d.). 
Epilepsy, characterized by recurrent seizures 
resulting in altered neurological function (Tippin, 
Sparks, & Rizzo, 2009), can pose a risk to road 
safety (Classen, Crizzle, Winter, Silver, & 
Eisenschenk, 2012; Sheth, Krauss, Krumholz, & Li, 
2004) due to impairments of motor, visual, and 
cognitive skills (Drazkowski, 2007).  One way to 
control seizures is through the use of antiepileptic 
drugs (AEDs).  While AEDs result in seizure 
remission in approximately two-thirds of people 
with epilepsy (World Health Organization, 2005), 
the side effects of some of these medications may 
impair multiple domains of cognition, such as 
memory and attention (Meador et al., 1995), and 
may cause blurred vision and/or fatigue 
(Drazkowski, 2007).  For example, topiramate, a 
commonly used AED, causes confusion, dizziness, 
fatigue, and decreased concentration in patients 
with seizures (Shorvon, 1996).  Another AED, 
zonisamide, produces other cognitive deficits, such 
as impairment of communication skills and recall of 
visual-graphic task stimuli, and may cause 
sleepiness in patients with partial seizures (Berent et 
al., 1987).  Because cognitive and visual processing 
skills are important to driving, AEDs may also 
adversely impact driving performance.  
In a double-blind randomized crossover 
study in 27 healthy drivers without neurological 
conditions, simulated driving performance was 
compared at baseline (no meds) and after dosages of 
either carbamazepine (CBZ) or oxcarbamazepine 
(OXC) were administered and progressively 
increased (Kaussner et al., 2010).  The participants 
made significantly more lane maintenance errors 
and more total driving errors when taking both 
AEDs.  When comparing the two drugs, the 
participants taking CBZ made significantly more 
total driving errors than when taking OXC, 
indicating that CBZ may have more adverse side 
effects on driving (Kaussner et al., 2010).  
Comparatively, another study examined the effects 
of AED dosages on driving performance in healthy 
drivers without neurological conditions on a road 
test (Ramaekers et al., 2002).  The participants were 
randomized into three groups (600 mg of CBZ vs. 
600 mg of remacemide vs. a placebo), and it was 
found that CBZ resulted in worse driving 
performance based on deviations of standard lane 
positioning compared to remacemide and the 
1
Crizzle et al.: Effects of AED dosage on driving performance
Published by ScholarWorks at WMU, 2015
  
 
placebo.  However, neither of these studies included 
persons with epilepsy or seizures.  The underlying 
impairment of seizures may also cause cognitive, 
motor, or visual impairment potentially leading to 
difficulties with driving further exacerbated by 
AED therapy.  
While the criterion measure for assessing 
driving performance is an on-road evaluation (Kay, 
Bundy, Clemson, & Jolly, 2008), the risk of 
seizures while driving places the driver, evaluator, 
passengers, and other road users at risk.  Although 
questions still remain on the utility of simulators in 
clinical practice for determining fitness to drive, 
research studies can use simulators to test driving 
performance in a safe, objective, and accurate 
manner (de Winter et al., 2009).  Research studies 
using simulators have found evidence of relative 
and absolute validity compared to on-road testing 
(Shechtman, Classen, Awadzi, & Mann, 2009).   
Only one study has prospectively examined 
simulated driving performance in people with 
epilepsy and found associations between clinical 
tests and driving errors (i.e., visual scanning, 
adjustment to stimuli, lane maintenance, vehicle 
position, and total errors), but that study did not 
examine specific AEDs or their dosages on driving 
performance (Crizzle et al., 2012).  Given that 
improving evidence-based practice is at the 
forefront of research agendas in occupational 
therapy, identifying features of medical conditions 
and associated medications that can impair driving 
is of paramount importance.  Thus, the objective of 
the present study was to describe the simulated 
driving performance (number and type of errors) in 
persons with seizures on their high vs. low AED 
dosages.  The primary aim of this study was 
twofold: (a) to identify simulated driving errors 
(e.g., lane maintenance, adjustment to stimuli, speed 
regulation, gap acceptance, signaling, visual 
scanning, and vehicle position) made during high 
and low AED dosage in persons with seizures; and 
(b) to determine if correlations existed between high 
and low AED dosage with specific and total number 
of simulated driving errors in persons with seizures.   
Method 
Participants 
 The Institutional Review Board at the 
University of Florida (UF) granted ethics approval, 
and each participant provided informed consent 
prior to participation.  Persons with epilepsy or 
seizures were referred to the UF in-patient Epilepsy 
Monitoring Unit (EMU) if they had refractory 
epilepsy, increased seizure frequency despite using 
AEDs, or had new variations of seizure activity 
(e.g., simple partial to complex partial) not 
exhibited previously.  The participants, referred by 
fellowship-trained epileptologists from the EMU, 
were eligible if: (a) they were 18 years or older, (b) 
showed evidence of paroxysmal events with loss of 
consciousness, (c) had a valid driver’s license or an 
intent to obtain one, (d) were community dwelling, 
and (e) had the physical and mental capacity to 
complete the study as determined by the 
epileptologist.  Exclusion criteria consisted of: (a) 
severe psychiatric (e.g., psychosis) and physical 
conditions (e.g., missing limbs), (b) multiple 
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psychotropic medications that negatively affect 
physical and cognitive function, and (c) pregnant 
females.  Two individuals were screened out due to 
meeting the exclusion criteria.  
Design   
 This quasi-experimental study employed a 
single group design to determine the effects of AED 
dosages on driving performance using a simulator.  
Participants in a single group were compared on 
their simulated driving performance while taking 
low and high dosages of AEDs.  As persons with 
epilepsy can have residual cognitive deficits from 
repeated seizures, a control group was not included 
as part of this study (as healthy adults are unlikely 
to have cognitive deficits).  
Procedure 
The participants were admitted to the EMU 
and monitored continuously (typically over 5 days) 
via electroencephalogram.  To elicit seizures, AED 
dosages were reduced or withdrawn under medical 
supervision.  The participants were tested on the 
simulator twice: first under their usual medication 
dosage (prescribed dosage) and then after having 
their AED’s reduced or withdrawn to elicit seizure 
activity.  To control for practice effects, six of the 
participants completed their first drive on their 
lowest AED dosage, followed by a second drive on 
their usual medications.  Alternatively, five 
participants completed their first drive on their 
usual medications followed by a second drive on 
their lowest AED dosage.  The participants’ exact 
AED dosages were obtained from medical records 
provided by the epileptologist.  Medications for all 
of the participants during the low and high AED 
dosage drives are shown in Table 1.  Low-dose 
AED was determined if the patient was taking < 
50% of the original AED doses at more than three 
half-lives for the specific AED prior to testing.  “No 
medications” was designated if AED(s) had been 
discontinued for more than three half-lives prior to 
testing.  The participants completed questionnaires 
on demographics, driving habits, and history, 
followed by driving on a high-fidelity DriveSafety 
DS-250r™ simulator, which is fully maneuverable 
on the EMU.  
 
Table 1 
Medication Type and Dosage Taken During High 
vs. Low AED Drives 
 
 
Participants Medication at 
high dosage 
Medication at 
low dosage 
#1 Lacosamide 200 mg Lacosamide 100mg 
#2 Zonisamide 100mg; 
Lacosamide 50mg 
No medications 
#3 Lamotrigine 150mg; 
Levetiracetam 
1000mg; 
Clonazepam 0.50mg 
Lamotrigine 50mg 
#4 Lamotrigine XR 
100mg; 
Oxcarbazepine 
750mg 
Lamotrigine XR 
50mg 
#5 Zonisamide 50mg No medications 
#6 Phenytoin 400 mg; 
Topiramate 200mg 
Topiramate 50mg 
#7 Zonisamide 300mg No medications 
#8 Levetiracetam 
1500mg 
No medications 
#9 Topiramate 50mg No medications 
#10 Levetiracetam 
1000mg 
No medications 
#11 Valproate 1500mg No medications 
3
Crizzle et al.: Effects of AED dosage on driving performance
Published by ScholarWorks at WMU, 2015
  
 
Driving Simulator and Scenarios 
The simulator design is based on a one-
fourth cab of an automatic transmission Ford Focus 
with a single adjustable seat and 5-point safety 
harness (see Figure 1).  To optimize driving close to 
the real world experience, the simulator was 
equipped with vehicle components (e.g., brake and 
gas pedal, air conditioning, turn signals).  The 
simulator has a high-resolution display (1024 x 748 
pixels) and provides the participants with a 110-
inch horizontal view across three screens (each 
screen is 19 inches).  The participants were required 
to adjust the seat and fasten the safety belt, and to 
control the steering wheel and gas and brake pedals. 
 
 
Figure 1. Portable DriveSafety DS-250 r™ simulator 
with a 5-point restraint 
 
To optimize comfort and confidence in 
driving the simulator, the participants completed 
three acclimation scenarios (driving in the middle of 
the lane, driving around curves, and stopping) 
lasting approximately 5 min each.  After the 
participants felt comfortable driving on the 
simulator, they drove a 35-min scenario while on 
low and high AED dosages (or vice versa), usually 
a few days apart.  A 35-min simulator drive has 
been employed in prior studies examining the 
influence of drugs (Brown, Milavetz, & Murry, 
2013), epilepsy (Crizzle et al., 2012), and 
obstructive sleep apnea (Vakulin et al., 2011).  The 
scenario was created to portray daylight and 
included ambient traffic but no turns.  The drive 
started in a rural setting, progressed to a commercial 
area, a freeway, and then to a residential area, with 
speed limits appropriately varying from 25-65 miles 
per hour.  The participants were instructed to 
identify all yellow road signs, exit signs, and 
billboards.  A clinical researcher, trained by a 
certified driving rehabilitation specialist with 98% 
of inter-rater reliability in test administration, 
evaluated the participants’ driving performance and 
recorded driving errors.  The Simulator Sickness 
Questionnaire (SSQ) (Kennedy, Lane, Berbaum, & 
Lilienthal, 1993) was administered to screen for 
simulator sickness symptoms before and after the 
participants completed three acclimation scenarios 
(curvy roads, stopping, and lane control) and after 
the main drive. 
 The driving errors the researcher recorded 
were: visual scanning, lane maintenance, speed 
regulation, vehicle position, adjustment to stimuli, 
signaling, gap acceptance, and yielding (Shechtman 
et al., 2009).  As detailed in a prior study (Crizzle et 
al., 2012), the drive also included three scripted 
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events that required the driver to avoid collisions: 
one at a train crossing and two where a car enters 
the driving lane from a parked position.  All of the 
participants had equal opportunities to make these 
errors over the two simulated drives. 
Data Analysis 
All data was entered into SPSS (version 
20.0) for analyses.  The researchers used descriptive 
statistics (mean, standard deviation, and range) to 
analyze continuous variables (i.e., number of 
driving errors) and frequencies (percent) to analyze 
categorical variables.  The researchers also used 
Spearman’s rank correlations to examine the 
associations between low and high AED dosages 
with the numbers of driving errors (total and type).  
Statistical significance was considered for alpha ≤. 
05 in a two-tailed test.  
Results 
Participants 
Twenty-two participants enrolled in the 
study; however, only 11 were able to complete the 
entire protocol.  Reasons for study incompletion 
included fatigue over the course of the hospital stay 
(e.g., being busy with family visitations) and the 
development of simulator sickness.  The sample (six 
women; five men) ranged from 32 to 51 years of 
age (mean age of 42.1 ± 6.3), had an average high 
school education (12.6 years ± 3.0), and was all 
Caucasian.  Eighty-two percent (n = 9) lived with 
their spouse or partner while two lived alone.  After 
admission to the EMU, seven were diagnosed with 
epilepsy and four with conversion disorders (non-
epileptic seizures).  We did not segregate by 
epilepsy and convergent disorders as there were no 
differences in driving performance between the 
groups (z = -.878, p = .38) and the patients in both 
groups were taking AEDs.  
Self-Reported Driving Habits and History 
The participants reported driving 2.9 ± 3.4 
days per week.  Six of the 11 participants had quit 
driving prior to EMU admission.  Two of the 
participants reported having been in a crash in the 
past three years, both current drivers.  Four of the 
participants reported receiving citations in the past 
three years—three of which reported speeding 
infractions (two former and one current driver) and 
one an improper turning citation (current driver).  
Twenty-seven percent (n = 3) of the sample 
reportedly avoided driving in the rain, during rush 
hour, on the highway, or at nighttime.  
Simulated Driving Performance 
Descriptive statistics for type and total 
number of driving errors during high and low AED 
dosages are provided in Table 2.  The most 
frequently committed driving errors in both low and 
high AED dosage drives included errors of speed 
regulation and lane maintenance.  Generally, the 
participants made more total driving errors, as well 
as errors of visual scanning and speed regulations, 
while on their high compared to low AED dosage.  
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Table 2  
Descriptive Statistics for Driving Errors between High and Low AED Drives 
     High Dosage     Low Dosage 
Driving Errors   M ± SD Range M ± SD Range  
Visual Scanning  3.8 ± 3.2 [0-10] 2.8 ± 3.3 [0-10]   
Speed Regulation  5.7 ± 5.5 [0-15] 5.0 ± 4.4 [0-13]   
Lane Maintenance   5.8 ± 4.1 [0-13] 6.1 ± 5.2 [1-18]   
Wide   2.5 ± 3.8 [0-13] 2.4 ± 5.3 [0-18]   
Encroach  3.4 ± 3.0 [0-8]  3.6 ± 3.1 [0-9]   
Signaling               .45 ± .69 [0-2]  .55 ± .82 [0-2]   
Vehicle Position  1.8 ± 2.2 [0-7]  1.7 ± 1.6 [0-4]  
Adjustment to Stimuli  .82 ± .98 [0-2]  .45 ± .69 [0-2]   
Gap Acceptance  36 ± .50 [0-1]  .18 ± .60 [0-2]   
Total Errors   19.0 ± 9.9 [6-43] 17.1 ± 8.9 [5-28]  
Note. M = mean, SD = standard deviation 
 
As shown in Table 3, high AED dosages 
were significantly associated with errors of lane 
maintenance and gap acceptance.  No associations 
between driving errors and low AED dosage were 
significant.  
 
 
Table 3 
Spearman’s Correlation Coefficient of Errors on High and Low Dosage AED Drives 
          High Dosage           Low Dosage 
Driving Errors     r    p     r    p 
Visual Scanning  .05  .88   .07  .84 
Speed Regulation  .05  .88   .30  .37 
Lane Maintenance   .49  .13   -.33  .33 
Wide   .67  .03*   -.44  .18 
Encroach  .01  .97   .01  .98 
Signaling               .15      .66   .32           .33 
Vehicle Position  .36  .27   .38  .26 
Adjustment to Stimuli  .51  .11   .48  .13 
Gap Acceptance  .66  .03*   .00  1.0 
Total Errors   .44  .18   .09  .78 
Note. r = correlation coefficient, * denotes significance on a 2-tailed test, p < .05 
 
 
Discussion 
The findings suggest that occupational 
therapists need to consider the effects of AEDs 
when assessing fitness to drive in persons with 
seizures.  Generally, the participants made more 
simulated driving errors while on their high 
compared to low AED dosages.  Consistent with a 
prior study (Crizzle et al., 2012), the most 
commonly committed errors in the present study 
were speed regulation and lane maintenance errors.  
Although individuals taking AED’s may have more 
difficulties with speed regulation and lane 
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maintenance, the findings suggest that driving may 
be affected for anyone taking AEDs for any reason, 
including pain, migraines, and mood disorders, 
consistent with prior findings (Kaussner et al., 
2010; Ramaekers et al., 2002).  This has 
implications not only for persons with seizures but 
also for patients with other medical conditions who 
use AEDs.  
 We found that high AED dosages in our 
sample were significantly associated with errors of 
lane maintenance (driving wide) and gap 
acceptance.  As AEDs impair aspects of cognition, 
namely attention (Drazkowski, 2007), information 
processing speed (Wesnes, Edgar, Dean, & Wroe, 
2009), and concentration (Shorvon, 1996), it is 
possible that our sample had more difficulty with 
proper lane maintenance and gap acceptance when 
taking high AED dosages.  As seven of the 11 
patients were actually unmedicated in the low 
dosage condition, it is also possible that there may 
have been a deterioration of simulator performance, 
which perhaps may have inflated the error measure 
in the low dosage condition overall.  Different AED 
classes may have variable effects on the central 
nervous system, and given that the group was 
administered the same drug treatment, it is difficult 
to draw any conclusions regarding a specific AED 
on simulated driving performance.  It is possible 
that certain AEDs may impair driving performance 
more so than others.  For example, prior studies 
have found that on-road and simulated driving 
performance was worse when taking CBZ when 
compared to both OXC (Kaussner et al., 2010) and 
remacemide (Ramaekers et al., 2002).  
Limitations 
The primary limitation of the present study 
was the small sample size (potential for type II 
error).  However, our sample acted as their own 
controls, and we did ensure practice effects were 
not confounded by drug dosage.  Although we 
recruited 22 participants for over two years, only 11 
participants met the criteria of driving under both 
high and low AED dosages while at the EMU.  Due 
to the loss of participants over the study protocol, 
our power to determine statistically meaningful 
inferences concerning the effects of different AED 
dosages on simulated driving performance was 
substantially reduced.  Even though we obtained 
medication profiles from the participants’ medical 
records, without monitoring AED serum levels 
(e.g., blood tests), we did not determine the actual 
AED dosage in their system at the time of the 
driving assessment.  As a result, we could not 
determine if patients were in a steady state or 
whether some tolerance had developed, although we 
attempted to assess patients on the simulator 
immediately after AEDs were administered at the 
EMU.  
Implications for Further Research 
Future prospective studies with larger 
homogenous samples are needed to discern the 
effects of specific AEDs and their respective 
dosages on driving performance in persons with 
seizures.  Additionally, there is a need to determine 
if the underlying epileptic focus has an impact on 
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driving performance regardless of AED dosing.  
While there were no differences between those with 
seizure and conversion disorders, there are 
important features that should be considered in 
future research.  For example, epileptic seizures 
affect the brain not only when they occur but in the 
interictal period as well.  Thus, any increase in their 
frequency (following lowering of drug dosages) 
could alter driving ability.  Conversely, as non-
epileptic seizures do not affect brain function, 
lowering of epileptic drugs in the non-epileptic 
group could lead to an improvement of brain 
function and driving ability measures.  Future 
studies should further assess those with seizures and 
conversion disorders to determine if there are any 
effects of AEDs on driving performance.  
Additionally, future studies should also use AED 
serum levels to ascertain the effects of AED 
concentrations on driving performance.  
Understanding the effects of AEDs on driving 
performance will enhance decision-making when 
prescribing AEDs, as well as occupational therapy 
practice with respect to driver assessment.  
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